Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality
Abstract Question: Are individuals who have hospital-based (emergency department or hospitalization) care for a cannabis use disorder (CUD) at increased…
Benedikt Fischer
Risk thresholds for the frequency of cannabis use during pregnancy and adverse neonatal outcomes: protocol for a systematic review and dose–response meta-analysis
Abstract Background: Cannabis use during pregnancy has been increasing and is associated with adverse neonatal outcomes, such as low birth…
Developments and Changes in Primary Public Health Outcome Indicators Associated with the Legalization of Non-Medical Cannabis Use and Supply in Canada (2018): A Comprehensive Overview
Abstract Canada legalized non-medical cannabis use and supply for adults in 2018. We examined developments and changes associated with the…
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
Abstract Rationale: The growing prevalence of psychostimulant (including amphetamine) use and associated health harms, with limited treatment options, present a…
The Lower-Risk Cannabis Use Guidelines’ (LRCUG) recommendations: How are Canadian cannabis users complying?
Abstract LRCUG feature recommendations for users on how to reduce cannabis use-related risks. Select cannabis use-related behavior data were identified…
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations
Abstract Issues: Non‐medical cannabis policies are changing, including towards legalisation‐with‐regulation frameworks. New Zealand will hold a public referendum on cannabis…
Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil
Abstract Cannabis is the most commonly used illegal drug, and is associated with well-documented adverse health outcomes, both acute and…
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders
Keywords: Cannabis, Hepatic disorders, Gastroenterological disorders, Position statement Authors: Christopher N Andrews, Shane M Devlin, Bernard Le Foll, Benedikt Fischer,…
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial
Abstract Background: The current lack of pharmacological treatments for cannabis use disorder (CUD) warrants novel approaches and further investigation of…